null

Phospho-Smad2-S465/467 + Smad3-S423/425 Antibody (CABP0548)

SKU:
CABP0548
Product Type:
Antibody
Applications:
WB
Reactivity:
Human
Mouse
Host Species:
Rabbit
Isotype:
IgG
Research Area:
Cell Biology
  • Cell Biology Antibodies 16 Anti-Phospho-Smad2-S465/467 Smad3-S423/425 Antibody CABP0548
  • Cell Biology Antibodies 16 Anti-Phospho-Smad2-S465/467 Smad3-S423/425 Antibody CABP0548
  • Cell Biology Antibodies 16 Anti-Phospho-Smad2-S465/467 Smad3-S423/425 Antibody CABP0548
  • Cell Biology Antibodies 16 Anti-Phospho-Smad2-S465/467 Smad3-S423/425 Antibody CABP0548
  • Cell Biology Antibodies 16 Anti-Phospho-Smad2-S465/467 Smad3-S423/425 Antibody CABP0548
€159 - €419
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

Anti-Phospho-Smad2-S465/467 + Smad3-S423/425 Antibody (CABP0548)

The Phospho-Smad2 (S465/467) / Smad3 (S423/425) Polyclonal Antibody (CABP0548) is a valuable tool for researchers studying the Smad2 and Smad3 proteins, key components of the TGF-beta signaling pathway. This antibody, raised in rabbits, is highly specific for phosphorylated Smad2 at serine 465/467 and phosphorylated Smad3 at serine 423/425 in human samples, allowing for accurate detection and analysis in Western blot applications. The TGF-beta signaling pathway is involved in numerous cellular processes, including cell growth, differentiation, and apoptosis. Dysregulation of this pathway has been implicated in various diseases, including cancer, fibrosis, and immune disorders.

The ability to specifically detect and study the phosphorylation status of Smad2 and Smad3 provides valuable insights into the molecular mechanisms underlying these diseases.By utilizing the Phospho-Smad2 (S465/467) / Smad3 (S423/425) Polyclonal Antibody, researchers can further our understanding of the TGF-beta signaling pathway and its role in disease pathogenesis. This antibody is a crucial tool for studies in cancer biology, immunology, and fibrosis research, ultimately paving the way for the development of novel therapeutic strategies targeting the TGF-beta pathway.